Innovate Corp

Innovate Corp(VATE)股票分析

$4.970

-0.421 (-8.47%)收盘时

Loading chart…
最高
5.520
开盘
5.270
成交量加权均价
5.15
成交量
83.53K
市值
88.63M
最低
4.970
成交额
430.48K
企业价值/息税折旧摊销前利润(TTM)
0.00

Innovate Corp. is a diversified holding company. The Company has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure (DBMG), Life Sciences (Pansend), and Spectrum. The DBMG segment consists of DBM Global Inc., which is a fully integrated construction company offering both construction and professional services primarily through its core subsidiaries. It provides services, including design-assist, modularization, fabrication and erection of structural steel, heavy steel plate, trusses and girders, heavy equipment installation, as well as facility services for maintenance and shutdowns. The Life Sciences segment consists of Pansend Life Sciences, LLC, which is focused on supporting healthcare and biotechnology product development. The Spectrum segment holds a 25% interest in HC2 Broadcasting Holdings Inc., which operates broadcast television stations throughout the United States.

AI 分析 of Innovate Corp (VATE)

持有

Innovate Corp (VATE) is currently not a strong buy due to its low RSI of 24, indicating oversold conditions, and a current price of $5.38, which is significantly below its 52-week high of $21.30. However, the forward P/E ratio of 4.86 suggests potential value if the company can stabilize its earnings. The main risk is its recent performance, with a 20-day change of -27.69%, indicating ongoing volatility.

估值指标

Innovate Corp(VATE)当前预期市盈率为 4.86,5 年平均预期市盈率为 -1.23。

预期市盈率

高估
5 年均值 P/E
-1.23
当前P/E
4.86
高估
1.94
低估
-4.41

预期 EV/EBITDA

严重低估
5 年均值 EV/EBITDA
41.92
当前EV/EBITDA
0.00
高估
47.04
低估
36.80

预期市销率

低估
5 年均值 P/S
0.12
当前P/S
0.00
高估
0.19
低估
0.04

事件时间线

2026-08-10 (ET)

11:00:00

Innovate Trading Halted, Volatility Trading Pause

09:00:00

INNOVATE Corp. Files $100M Mixed Securities Shelf

08:30:00

IES Holdings to Acquire DBM Global for $650M

2026-02-02 (ET)

09:00:00

INNOVATE Announces DBM Global to Pay $5M Cash Dividend

2025-12-16 (ET)

08:10:00

INNOVATE Announces MediBeacon FDA Approval for Next-Gen TGFRTM System

资讯

VATE 常见问题 —— 由 Alphio AI 解答

Innovate Corp. is a diversified holding company. The Company has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure (DBMG), Life Sciences (Pansend), and Spectrum. The DBMG segment consists of DBM Global Inc., which is a fully integrated construction company offering both construction and professional services primarily through its core subsidiaries. It provides services, including design-assist, modularization, fabrication and erection of structural steel, heavy steel plate, trusses and girders, heavy equipment installation, as well as facility services for maintenance and shutdowns. The Life Sciences segment consists of Pansend Life Sciences, LLC, which is focused on supporting healthcare and biotechnology product development. The Spectrum segment holds a 25% interest in HC2 Broadcasting Holdings Inc., which operates broadcast television stations throughout the United States. It operates in the Industrials sector (FABRICATED STRUCTURAL METAL PRODUCTS industry).

Innovate Corp (VATE) is currently not a strong buy due to its low RSI of 24, indicating oversold conditions, and a current price of $5.38, which is significantly below its 52-week high of $21.30. However, the forward P/E ratio of 4.86 suggests potential value if the company can stabilize its earnings. The main risk is its recent performance, with a 20-day change of -27.69%, indicating ongoing volatility.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易